-+ 0.00%
-+ 0.00%
-+ 0.00%

Novartis Reaffirms Low Single-Digit Net Sales Growth Guidance For 2026; Priority Brands Kisqali, Scemblix And Leqvio Post Strong Double-Digit Gains In Q2

Benzinga·07/21/2026 05:10:49
Listen to the news

Full-year 2026 guidance reaffirmed o Net sales expected to grow low single-digit and core operating income expected to decline low single-digit